Corrigendum to “Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways” [Neuropharmacol. (2021) 1, 197, 108738]

IF 4.6 2区医学 Q1 NEUROSCIENCES

Neuropharmacology Pub Date : 2024-05-18 DOI:10.1016/j.neuropharm.2024.109989

Shaimaa S. Ibrahim, Omar G. Abo Elseoud, M. Mohamedy, Mohamed M. Amer, Youssef Y. Mohamed, Shehab A. Elmansy, Mohamed M. Kadry, Ahmed A. Attia, Ragy A. Fanous, Mahmoud S. Kamel, Youssef A. Solyman, Mazen S. Shehata, Mina Y. George

引用次数: 0

查看原文本刊更多论文

更正："在多柔比星诱导的大鼠认知障碍中，从鼻到脑递送金丝桃素转移体和复合囊泡：配方、氧化应激和TLR4/NF-kB/NLRP3通路的启示" [Neuropharmacol.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuropharmacology 医学-神经科学

CiteScore

10.00

自引率

4.30%

发文量

288

审稿时长

45 days

期刊介绍： Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).